|
Vol 26- Dec
2009
|
New RMI board
Chairman
An Auckland lawyer with a
background
in international banking and extensive links across New Zealand’s
public and private sectors, has been appointed RMI
chairman. Lex Henry (pictured right), a Special Counsel
with Auckland law firm Minter Ellison Rudd Watts, also currently
chairs merchant bank Cranleigh, and is a Director of Ngai Tahu
Properties and health software company MedTech. He is also a
member of the Auckland University of Technology Council and AUT
Millennium Institute. The Deputy Chair of the TransTasman
Business Circle, and a Trustee of the Christchurch Arts Festival and
the Asia NZ Foundation, until recently Mr Henry was a Landcorp
director and the Deputy Chairman of OnTrack (KiwiRail). He has
also served as a New Zealand diplomat covering ASEAN.
Photo
Mark Coote. |
New RMI
vision and mission
statement Changes to the wording of the RMI
vision and mission were touched on in a speech given by the CEO at
this year’s Christmas function. The December meeting of the RMI
Board approved the changes, as well as a rewording of the RMI core
Values.
Vision: To improve health outcomes for
New Zealanders through equitable access to quality
medicines.
Our Mission: To advocate for
patients’ needs by influencing public policy to achieve equitable
access to quality medicines.
Core
values: • Ethical: we take a
responsible approach and use evidence-based
arguments. • Accountable: we are cognisant of our
responsibility to our members and to New
Zealanders. • Collaborative: we recognise the
fiscal pressures of providing health services and offer solutions
before criticism. • Pro-active: we are forward
looking and seek to drive positive
change. • Committed: we are focused on the
challenges of achieving
equity.
|
Good turnout for RMI
Christmas function Wellington’s
Faultline Chorus entertained at this year’s RMI Christmas function
where guests included politicians, media and Government department
representatives, as well as patient and industry
groups.
The evening
was MC’d by sanofi-aventis Country Manager, Alan Carter, who
introduced new RMI Board chairman, Lex Henry, and new CEO, Denise
Wood, to around 50 invitees. Mr Henry and Ms Wood’s speeches are
reproduced later in this newsletter.
For more photographs
of the evening click here. |

(L-R) Stefan Crausaz and
Lisa Williams (PHARMAC)
and Sarah Thomson
(Diabetes NZ). |
|

(L-R) Kevin Sheehy (RMI)
and Graeme Peters (AGCarm).
|
|

(L-R)
Lesley Clarke (McKesson), Kim Miles (NZ
Orthapaedic Association) and Michael Woodhouse,
MP. Photos Mark
Coote |
Excerpts from Lex
Henry’s speech at the RMI Christmas
event
“Kia Ora. Can I
thank all of you for accepting our invitation. I would like to
specifically acknowledge Dr Pippa MacKay, the most recent chairman
of the RMI for her commitment to the organisation, and also Dick
[Richard] Nottage who was also chairman, and someone whose
considerable international skills can be called on as we move
forward with the Trans Pacific Partnership. I have a
strong interest in health through iwi, University, law, medical
software and merchant banking – but most importantly I receive a
twice daily briefing from a clinical team leader for dental services
in Auckland – coincidently, that clinical team leader is my wife,
Lyn. What she constantly emphasises is the need for a
patient-centric health environment. I agree with her – it’s hard not
to. However, we are at the cusp of major change in our
health sector - the funding challenges; the need to deliver
high quality primary health outcomes; the need to ensure that
the reforms which Murray Horn and others have recommended are
implemented; the need to support pharmaceutical research and to
protect the intellectual property which results. The key
question for me is whether New Zealand is getting optimal
performance from its health sector. I do not think so. I
am sure that representatives of Breast Cancer, Diabetes and
Arthritis groups would have comments to make. Are we
taking steps to improve? Definitely yes, as evidenced from the
Horn Report and crucial initiatives such as PHARMAC’s inaugural
Hiwinui Heke Scholarship. The pharmaceutical industry has
a significant role to play in New Zealand. We need to see increased
involvement in New Zealand Research and Development, especially with
a burgeoning biotech sector. What’s needed (no pun
intended) is a healthy but short debate about performance of the
sector. The presence here of MPs, officials, Colleges and
Practitioners Association, Business New Zealand, media and
diplomatic representatives illustrates that the debate can occur.
And we also need to include the Universities and research
organisations. Thank you for being here. Festive
Greetings, and may 2010 see a very healthy
debate.”
|
|
Speech from RMI CEO Denise
Wood
"Good evening everyone. I may have been in this
role just a few short weeks, but I have been engaged in the health
sector for many years. I join the RMI at a very exciting time
for the healthcare industry. I haven’t had much of a
honeymoon period, as we have got straight on with the business of
redefining our strategy to ensure we are focussing on placing the
patient at the centre of everything we do. When we meet
again in a year’s time, I expect you to hold us accountable
for our performance against our new vision and mission. Likewise we
will be holding our stakeholders accountable for their contribution
to the changing healthcare environment. I look forward to
meeting you this evening and working with you through 2010. Please
enjoy your evening and I wish you and your families a very peaceful
Christmas and New Year."
|
 |
This newsletter is published on behalf
of the Researched Medicines Industry Association of New
Zealand. The views and opinions expressed in this publication
are not necessarily those of the RMI.
For further
information: Researched
Medicines Industry Association PO Box 10447
Wellington Phone 04 499 4277 http://www.rmianz.co.nz info@rmianz.co.nz
| | |
|
RMI to survey
stakeholders
The RMI is to conduct an online survey to gauge
stakeholder perception of the organisation’s issues and challenges.
RMI CEO, Denise Wood, says a wide range of
groups around the country will be asked to take part. These include
key media, politicians, patient advocates, health professionals,
Maori and Pacific Island health providers, Government departments,
business and research groups and RMI members.
“The RMI is keen to receive feedback on how
effective the organisation is, and how well its work and role within
New Zealand’s health sector is understood within the community,” Ms
Wood says.
“This is a period of change for the RMI, and
knowing our stakeholders views on a range of issues will greatly
assist us over the next few years,” she said.
The survey will run from late January until
early February, with results collated in time for the RMI AGM in
March.
Upcoming
events
- 30-31 March - Healthcare in Asia 2010 - investing
in tomorrow. Venue: The Fullerton Hotel,
Singapore. Contact christopherluk@economist.com
and
all the best for 2010 from the staff at the RMI - Denise
Wood, Kevin Sheehy and Michelle
Gibbs.
Note - the RMI office will close
at noon Christmas Eve and open again Monday, 11th January
2010.
www.rmianz.co.nz
|
|